POLYSERP

Serial Number 88658360
Registration 6356887
700

Registration Progress

Application Filed
Oct 17, 2019
Under Examination
Oct 20, 2020
Approved for Publication
Aug 25, 2020
Published for Opposition
Aug 25, 2020
Registered
May 18, 2021

Trademark Image

POLYSERP

Basic Information

Serial Number
88658360
Registration Number
6356887
Filing Date
October 17, 2019
Registration Date
May 18, 2021
Published for Opposition
August 25, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 18, 2021
Registration
Registered
Classes
005

Rights Holder

CRO, LLC

16
Address
516 E SPRUCE ST
MISSOULA, MT 59802

Ownership History

CRO Pharmaceuticals, LLC

Original Applicant
16
Missoula, MT

CRO Pharmaceuticals, LLC

Owner at Publication
16
Missoula, MT

CRO Pharmaceuticals, LLC

Original Registrant
16
Missoula, MT

CRO PHARMACEUTICALS, LLC

New Owner After Registration #1
16
MISSOULA, MT

CRO, LLC

New Owner After Registration #2
16
MISSOULA, MT

Legal Representation

Attorney
Martin Rogers

USPTO Deadlines

Next Deadline
467 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210518)
Due Date
May 18, 2027
Grace Period Ends
November 18, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
May 25, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 8, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 18, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 15, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 14, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 30, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 10, 2021 IUAF S USE AMENDMENT FILED Loading...
Mar 29, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 10, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 20, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 25, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 25, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 5, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 17, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 9, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 9, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 7, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 30, 2020 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Loading...
Jan 30, 2020 ALIE A ASSIGNED TO LIE Loading...
Jan 30, 2020 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jan 30, 2020 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jan 30, 2020 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Jan 23, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 21, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 21, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and veterinary preparations for the treatment of envenomation; chemical reagents for medical and veterinary purposes for the treatment of envenomation; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation; chemico-pharmaceutical preparations for the treatment of envenomation; medicines for the treatment of envenomation; venom antidotes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation; envenomation anti-venom antidotes
First Use Anywhere: Jan 1, 2021
First Use in Commerce: Jan 1, 2021

Classification

International Classes
005